Surveillance for low-risk or low- intermediate risk non-muscle invasive bladder cancer: A Pilot Study
This is a two-arm, randomized-controlled study. For the purposes of enrollment [Quote]intervention[Quote] refers to surveillance based on the eau guidelines and [Quote]control[Quote] refers to surveillance based on the aua guidelines.
The patient must:
- Have one negative cystoscopy 3 months following most recent biopsy
- Be able to give informed consent
- Be age 18 or older
- Be at low- or low-intermediate risk for disease recurrence and progression according to
the EAU guidelines